These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 14688368)

  • 1. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.
    Williams L; Bradley L; Smith A; Foxwell B
    J Immunol; 2004 Jan; 172(1):567-76. PubMed ID: 14688368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.
    Niemand C; Nimmesgern A; Haan S; Fischer P; Schaper F; Rossaint R; Heinrich PC; Müller-Newen G
    J Immunol; 2003 Mar; 170(6):3263-72. PubMed ID: 12626585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.
    Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F
    J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling.
    Kim H; Suh JM; Hwang ES; Kim DW; Chung HK; Song JH; Hwang JH; Park KC; Ro HK; Jo EK; Chang JS; Lee TH; Lee MS; Kohn LD; Shong M
    J Immunol; 2003 Jul; 171(2):616-27. PubMed ID: 12847226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways.
    Ahmed ST; Ivashkiv LB
    J Immunol; 2000 Nov; 165(9):5227-37. PubMed ID: 11046056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10.
    Crepaldi L; Gasperini S; Lapinet JA; Calzetti F; Pinardi C; Liu Y; Zurawski S; de Waal Malefyt R; Moore KW; Cassatella MA
    J Immunol; 2001 Aug; 167(4):2312-22. PubMed ID: 11490020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
    Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
    Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
    J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
    Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
    J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.
    O'Farrell AM; Liu Y; Moore KW; Mui AL
    EMBO J; 1998 Feb; 17(4):1006-18. PubMed ID: 9463379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming of IL-10 activity and signaling by IFN-gamma.
    Herrero C; Hu X; Li WP; Samuels S; Sharif MN; Kotenko S; Ivashkiv LB
    J Immunol; 2003 Nov; 171(10):5034-41. PubMed ID: 14607900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
    Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
    J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
    Tanuma N; Shima H; Nakamura K; Kikuchi K
    Blood; 2001 Nov; 98(10):3030-4. PubMed ID: 11698287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
    Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
    Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
    Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports Toll-like receptor 4 signaling in murine peritoneal macrophages.
    Cao X; Wei G; Fang H; Guo J; Weinstein M; Marsh CB; Ostrowski MC; Tridandapani S
    J Immunol; 2004 Apr; 172(8):4851-7. PubMed ID: 15067063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis.
    Sharif MN; Tassiulas I; Hu Y; Mecklenbräuker I; Tarakhovsky A; Ivashkiv LB
    J Immunol; 2004 May; 172(10):6476-81. PubMed ID: 15128840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
    Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
    Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
    Chen CW; Chang YH; Tsi CJ; Lin WW
    J Immunol; 2003 Jul; 171(2):979-88. PubMed ID: 12847270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages.
    Wesemann DR; Dong Y; O'Keefe GM; Nguyen VT; Benveniste EN
    J Immunol; 2002 Sep; 169(5):2354-60. PubMed ID: 12193701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.